Logo

Synopsis Indian pharma companies are going global and emerging as MNCs. Even though Indian pharma started to internationalize in the 1960s, it gained momentum only in the 90s and the trend continues to increase in the current decade. Initially, Indian companies targeted emerging nations to globalize and now they are focusing both on developed and developing countries. There are huge opportunities available for Indian companies to tap worldwide due to the increase in population and disease. As the developing countries embrace globalization and urbanization, the lifestyle of people in there is undergoing major changes and it causes many diseases that are similar to those of the developed world. Hence, tremendous opportunities exist for Indian companies in developed markets like the US, Europe and Japan as well as developing markets like Brazil Russia, India, China, South Africa, and Mexico. Most of the pharma majors' blockbuster drugs will go off patent in the coming years. This also spells out great opportunities especially for generic drug manufacturers. In order to tap these opportunities, Indian companies are going global through exports, Joint Ventures, Mergers & Acquisitions and Greenfield Investments. Indian companies are also engaging in Contract Research and Manufacturing Services. On the other hand, Indian companies are also out-licensing their products to global pharma firms. This book "Indian Pharma - Going Global" gives insights into the various strategies followed by Indian companies to go global, various markets tapped by them and their experiences in globalization.